BeOne Medicines Ltd. (ONC)

↓ Download CSV

CIK 0001651308 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, BeOne Medicines Ltd. reported revenue of $5.34B, up 40.2% from the prior year. The company was profitable, with a net margin of 5.4% and a gross margin of 87.5%. It held $8.19B in total assets against $3.83B in total liabilities.

Key ratios (FY2025)

87.5%
Gross margin
8.4%
Operating margin
5.4%
Net margin
6.6%
Return on equity
+40.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$5.34B$3.81B$2.46B$1.42B$1.18B$308.87M$428.21M$198.22M$238.39M$1.07M
Cost of Revenue$286.48M$164.91M$70.66M$71.19M$28.70M$4.97M$0
Gross Profit$4.67B$3.22B$2.08B$1.13B$1.01B
Operating Income$447.14M-$568.20M-$1.21B-$1.79B-$1.44B-$1.66B-$959.89M-$705.77M-$98.46M-$117.06M
Net Income$286.93M-$644.79M-$881.71M-$2.00B-$1.46B-$1.62B-$948.63M-$673.77M-$93.11M-$119.22M
EPS (Diluted)$0.19$-0.47$-0.65$-1.49$-1.21$-1.50$-1.22
Total Assets$8.19B$5.92B$5.81B$6.38B$8.54B$5.60B$1.61B$2.25B$1.05B$405.81M
Total Liabilities$3.83B$2.59B$2.27B$2.00B$2.40B$1.73B$633.93M$496.04M$362.25M$52.91M
Shareholders' Equity$4.36B$3.33B$3.54B$4.38B$6.13B$3.87B$962.21M$1.74B$669.81M$352.91M
Cash & Equivalents$4.55B$2.63B$3.17B$3.87B$4.38B$1.38B$618.01M$712.94M$239.60M$87.51M
Operating Cash Flow$1.13B-$140.63M-$1.16B-$1.50B-$1.30B-$1.28B-$750.27M-$547.72M$12.75M-$89.51M
Capital Expenditures$185.84M$492.66M$561.90M$325.43M$262.94M$117.51M$89.61M$70.28M$46.37M$23.50M
Shares Outstanding1.44B1.39B1.36B1.36B1.33B1.19B801.34M776.26M592.07M515.83M